Is London Stock Exchange Group a Buy After Share Price Slump?
Key Takeaways
- Despite a year over year rise in London Stock Exchange Group’s income and profits, its stock price has fallen 25%.
- LSEG is facing competition from new AI models and rivals like Bloomberg.
- Recent negative news about listings and IPOs includes a possible move by AstraZeneca from London to the New York Stock Exchange.
The London Stock Exchange Group’s LSEG share price has fallen by a quarter this year, making the stock one of the worst performers in the UK market in Q3.
Investment confidence has increasingly waned, as investors weigh up the likely impact of the artificial intelligence boom on LSEG’s data and analytics division.
The dramatic fall in LSEG stock leaves the company, which owns the UK’s main stock market, on…
